Find clinical trials for Non-Small-Cell Lung Cancer in Rochester, MN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Small-Cell Lung Cancer trials near Rochester, MN, USA:
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell...
Phase 2
Rochester, Minnesota, United States and 83 other locations
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the-...
Phase 3
Rochester, Minnesota, United States and 290 other locations
combination with standard of care carboplatin and pemetrexed) in 21 day treatment cycle for participants with advanced non-small c ...
Phase 1
Rochester, Minnesota, United States and 72 other locations
This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...
Phase 2
Rochester, Minnesota, United States and 254 other locations
Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and untreated non-small cell lung cancer (NSCLC) t...
Phase 2
Rochester, Minnesota, United States and 37 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell...
Phase 3
Rochester, Minnesota, United States and 305 other locations
The purpose of this study is to assess the safety and efficacy of multiple study interventions including novel-novel combinations or novel agents in...
Phase 1, Phase 2
Rochester, Minnesota, United States and 88 other locations
study population comprises adults with either advanced/metastatic non-small cell lung cancer (NSCLC) wit...
Phase 1, Phase 2
Rochester, Minnesota, United States and 43 other locations
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with adagrasib in patients with G12C Non-Small...
Phase 1, Phase 2
Rochester, Minnesota, United States and 7 other locations
survival (OS) in treatment-naïve metastatic participants with non-small cell lung cancer (NSCLC)....
Phase 3
Rochester, Minnesota, United States and 148 other locations
Clinical trials
Research sites
Resources
Legal